Hip fractures are a frequent cause of acute hospitalization in the elderly population. As the population continues to age, the incidence is expected to increase. Because many hip fracture patients suffer from multiple medical comorbidities, hospitalists increasingly play a critical role in their care. Management of hip fracture patients requires knowledge of multiple consultative medicine topics, including preoperative cardiac and pulmonary risk stratification and reduction strategies, venous thromboembolism prevention, and diagnosis and management of common postoperative complications. Open lines of communication between the hospitalist, surgeon, and anesthesiologist are also essential to optimize patient care.
After completing the module, the participant should be able to:
- Summarize the epidemiology of hip fractures and the role of the hospitalist.
- Elucidate the optimal timing for surgical repair of a hip fracture to improve patient outcomes.
- Perform an appropriate, evidence-based preoperative medical evaluation for patients undergoing hip fracture repair.
- Recognize the importance and reduce the risk of venous thromboembolism in hip fracture patients.
- Appreciate common postoperative medical complications associated with hip fracture surgery and apply risk reduction strategies.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: December 1, 2008. Expiration date: December 1, 2010.
*Clinical Instructor, Director, Preoperative Clinic and General Medicine Consult Service, Division of General Medicine, University of Michigan Health System, Ann Arbor, Michigan.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.